Estrogen attenuates gp120- and tat1-72-induced oxidative stress and prevents loss of dopamine transporter function

Synapse

Volumn 59, Issue 1, 2006, Pages 51-60

  Wallace, David R ^a   Dodson, Stephanie ^a   Nath, Avindra ^b   Booze, Rosemarie M ^c  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Dopamine transporter; Estrogen; gp120; HIV; Oxidative stress; Tat

Indexed keywords

ANTIESTROGEN; DICHLOROFLUORESCEIN; DOPAMINE; DOPAMINE TRANSPORTER; ESTRADIOL; ESTROGEN; FULVESTRANT; GLYCOPROTEIN GP 120; LINSIDOMINE; PEROXYNITRITE; PROGESTERONE; TAT PROTEIN[1-72]; TRANSACTIVATOR PROTEIN; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN SYNAPTOSOME; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DEMENTIA; DOPAMINE UPTAKE; FLUORESCENCE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; RAT;

ANIMALS; CELL LINE, TUMOR; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; ESTRADIOL; FLUORESCEINS; GENE PRODUCTS, TAT; HIV ENVELOPE PROTEIN GP120; HUMANS; MALE; MOLSIDOMINE; NEUROBLASTOMA; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTOSOMES; TIME FACTORS; TRITIUM;

EID: 28244481907     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20214     Document Type: Article

References (59)

1. Aksenov MY, Hallelrot U, Bansai AK, Wu G, Nath A, Anderson C, Mactutus C, Booze RM. 2001. Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum. Neurosci Lett 305:5-8.
2. Aksenov MY, Hallelrot U, Wu G, Nath A, Anderson C, Mactutus C, Booze RM. 2003. Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum. Brain Res 987:1-9.
3. -: evaluations using in vitro and in vivo techniques. Brain Res 872:160-172.
4. 2- channel modulation in the neuroprotective actions of estrogen in β-amyloid protein and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) cytotoxic models. Neurochem Int 45:31-38.
5. Ba F, Pang PKT, Davidge ST, Benishin CG. 2004b. The neuroprotective effects of estrogen in SK-N-SH neuroblastoma cell cultures. Neurochem Int 44:401-411.
6. Bagetta G, Corasaniti MT, Paoletti AM, Berliocchi L, Nistico R, Giammarioli AM, Malorni W, Finazzi-Agro A. 1998. HIV-1 gp120-induced apoptosis in the rat neocortex involves enhanced expression of cyclo-oxygenase type2 (COX-2). Biochem Biophys Res Comm 244:819-824.
7. Bansal AK, Mactutus CF, Nath A, Maragos W, Hauser KF, Booze RM. 2000. Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Brain Res 879:42-49.
8. Biedler JL, Helson L, Spengler BA. 1973. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643-2652.
9. Boven LA, Gomes L, Hery C, Gray F, Verhoef J, Portegies P, Tardieu M, Nottet HSLM. 1999. Increased peroxynitrite activity in AIDS dementia complex: Implications for the neuropathogenesis of HIV-1 infection. J Immunol 162:4319-4327.
10. Brooke SM, Sapolsky RM. 2000. The effects of steroid hormones in HIV-related neurotoxicity: A mini review. Biol Psychiatry 48:881-893.
11. Callier S, Morissette M, Grandbois M, Di Paolo T. 2000. Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice. Synapse 37:245-251.
12. Catani MV, Corasaniti MT, Navarra M, Nistico G, Finazzi-Agro A, Melino G. 2000. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors. J Neurochem 74:2373-2379.
13. Clark RA, Bessinger R. 1997. Clinical manifestations and predictors of survival in older women infected with HIV. J Acquir Immune Defic Syndr Hum Retroviol 15:341-345.
14. Constantine GD, Pickar JH. 2003. Estrogens in postmenopausal women: recent insights. Curr Opin Pharmacol 3:626-634.
15. Corasaniti MT, Bagetta G, Rotiroti D, Nistico G. 1998. The HIV envelope protein gp120 in the nervous system: interactions with nitric oxide, interleukin-1β and nerve growth factor signaling, with pathological implications in vivo and in vitro. Biochem Pharmacol 56:153-156.
16. Currie LJ, Harrison MB, Trugman JM, Bennett JP, Wooten GF. 2004. Postmenopausal estrogen use affects risk for Parkinson Disease. Arch Neurol 61:886-888.
17. Disshon KA, Boja JW, Dluzen DE. 1998. Inhibition of striatal dopamine transporter activity by 17β-estradiol. Eur J Pharmacol 345:207-211.
18. Dluzen DE, McDermott JL, Anderson LI. 2001. Tamoxifen eliminates estrogen's neuroprotective effect upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system. Neurotoxicol Res 3:291-300.
19. Gao X, Dluzen DE. 2001. Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system. Neuroscience 103:385-394.
20. Garcia-Segura LM, Azcoitia I, DonCarlos LL. 2001. Neuroprotection by estradiol. Prog Neurobiol 63:29-60.
21. Gavriil ES, Cooney R, Weeks BS. 2000. Tat mediates apoptosis in vivo in the rat central nervous system. Biochem Biophys Res Comm 267:252-256.
22. Green PS, Simpkins JW. 2000. Neuroprotective effects of estrogens: potential mechanism of action. Int J Dev Neurosci 18:347-358.
23. Green PS, Gridley KE, Simpkins JW. 1996. Estradiol protects against β-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci Lett 218:165-168.
24. Green PS, Bishop J, Simpkins JW, 1997a. 17α-Estradiol exerts neuroprotective effects on SK-N-SH cells. J Neurosci 17:511-515.
25. Green PS, Gordon K, Simpkins JW. 1997b. Phenolic A ring requirement for the neuroprotective effects of steroids. J Steroid Biochem Mol Biol 63:229-235.
26. Green PS, Yang SH, Nilsson KR, Kumar AS, Covey DF, Simpkins JW. 2001. The nonfeminizing enantiomer of 17β-estradiol exerts protective effects in neuronal cultures and a rat model of cerebral ischemia. Endocinol 142:400-406.
27. Gridley KE, Green PS, Simpkins JW. 1997. Low concentrations of estradiol reduce β-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Res 778:158-165.
28. Gridley KE, Green PS, Simpkins JW. 1998. A novel, synergistic interaction between 17 β-estradiol and glutathione in the protection of neurons against β-amyloid 25-35-induced toxicity in vitro. Mol Pharmacol 54:874-880.
29. Gurwell JA, Nath A, Sun Q, Zhang J, Martin KM, Chen Y, Hauser KF. 2001. Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 tat protein in striatal neurons in vitro. Neurosci 102:555-563.
30. Haughey NJ, Holden CP, Nath A, Geiger JD. 1999. Involvement of inositol 1,4,5-triphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein Tat. J Neurochem 73:1363-1374.
31. Hawkins V, Shen Q, Chiueh CC. 1999. Kynostatin and 17β-estradiol prevent the apbptotic death of human neuroblastoma cells exposed to HIV-1 protease. Biomed Sci 6:433-438.
32. Jain SK, Kannan K, Prouty L, Jain SK. 2004. Progesterone, but not 17β-estradiol, increases TNF-α secretion in U937 monocytes. Cytokine 26:102-105.
33. Jones M, Olafson K, Del Bigio MR, Peeling J, Nath A. 1998. Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliois, apoptosis, and ventricular enlargement. J Neuropathol Exp Neurol 57:563-570.
34. Kruman II, Nath A, Mattson MP. 1998. HIV-1 protein Tat induces apoptosis of Hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 154:276-288.
35. Lee YW, Eum SY, Nath A, Toborek M. 2004. Estrogen-mediated protection against HIV Tat protein-induced inflammatory pathways in human vascular endothelial cells. Cardiovasc Res 63:139-148.
36. Ma M, Nath A. 1997. Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol 71:2495-2499.
37. Meucci O, Miller RJ. 1996. gp120-induced neurotoxicity in Hippocampal pyramidal neuron cultures: protective action of TGF-β1. J Neurosci 16:4080-4088.
38. Murphy SJ, Traystman RJ, Hurn PD. 2000. Progesterone exacerbated striatal stroke injury in progesterone-deficient female animals. Stroke 31:1173-1178.
39. Muscoli C, Salvemini D, Paolino D, Iannone M, Palma E, Cufari A, Rotiroti D, Perno CF, Aquaro S, Mollace V. 2002. Peroxynitrite decomposition catalyst prevents apoptotic cell death in a human astrocytoma cell line incubated with supernatants of HIV-infected macrophages. BMC Neuroscience 3:13.
40. Nath A, Psooy K, Martin C, Knudsen B, Magnuson DSK, Haughey N, Geiger JD. 1996. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol 70:1475-1480.
41. Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, Geiger JD. 2000. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol 47:186-194.
42. New DR, Maggirwar SB, Epstein LG, Dewhurst S, Gelbard HA. 1998. HIV-1 Tat induces neuronal death via tumor necrosis factor-α and activation of non-N-methyl-D-aspartate receptors by a NFκB-independent mechanism. J Biol Chem 273:17852-17858.
43. Picazo O, Azoitia I, Garcia-Segura LM. 2003. Neuroprotective and neurotoxic effects of estrogen. Brain Res 990:20-27.
44. Polazzi E, Giulio L, Minghetti L. 1999. Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures. J Neuropathol Exp Neurol 58:825-831.
45. Prendergast MA, Rogers DT, Mulholland PJ, Littleton JM, Wilkins LH, Self RL, Nath A. 2002. Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require a function of a polyamine sensitive-site on the N-methyl-D-aspartate receptor. Brain Res 954:300-307.
46. Raber J, Toggas SM, Lee S, Bloom FE, Epstein CJ, Mucke L. 1996. Central nervous system expression of HIV-1 gp120 activates the hypothalamic-pituitary- adrenal axis: evidence for involvement of the NMDA receptors and nitric oxide synthase. Virology 226:362-373.
47. Schneider LS. 2004. Estrogen and dementia: insights from the Woman's Health Initiative Memory Study. JAMA 291:3005-3007.
48. 2+ that require function of an N-methyl-D-aspartate receptor polyamine-sensitive site. Brain Res 885:39-45.
49. Smith SM, Baskin GB, Marx PA. 2000. Estrogen protects against vaginal transmission of simian immunodeficiency virus. J Infect Dis 182:708-715.
50. Takao T, Flint N, Lee L, Ying X, Merrill J, Chandross KJ. 2004. 17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death. J Neurochem 89:660-673.
51. Thompson TL. 1999. Attenuation of dopamine uptake in vivo following priming with estradiol benzoate. Brain Res 834:164-167.
52. Thompson TL, Moss RL. 1994. Estrogen regulation of dopamine release in the nucleus accumbens: genomic and nongenomic-mediated effects. J Neurochem 229:145-148.
53. Toader V, Xu X, Nicolescu A, Yu L, Bolton JL, Thatcher GRJ. 2003. Nitrosation, nitration and autoxidation of the selective estrogen receptor modulator raloxifene by nitric oxide, peroxynitrite and reactive nitrogen/oxygen species. Chem Res Toxicol 16:1264-1276.
54. Turchan J, Anderson C, Hauser KF, Sun Q, Zhang J, Liu Y, Wise PM, Kruman I, Maragos W, Mattson MP, Booze R, Nath A. 2001. Estrogen protects against the synergist toxicity by HIV proteins, methamphetamine and cocaine. BMC Neuroscience 2:3.
55. Wang H, Joseph JA. 1999. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Rad Biol Med 27:612-616.
56. Wang GJ, Chang L, Volkow ND, Telang F, Logan J, Ernst T, Fowler JS. 2004. Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 127:2452-2458.
57. Xia S, Cai ZY, Thio LL, Kim-Han JS, Dugan LL, Covey DF, Rothman SM. 2002. The estrogen receptor is not essential for all estrogen neuroprotection: new evidence from a new analog. Neurobiol Dis 9:282-293.
58. Yeung MC, Geertsma F, Liu J, Lau AS. 1998. Inhibition of HIV-1 gp120-induced apoptosis in neuroblastoma SK-N-SH cells by an antisense oligodeoxynucleotide against p53. AIDS 12:349-354.
59. Zaulyanov LL, Green PS, Simpkins JW. 1999. Glutamate receptor requirements for neuronal death from anoxia-reoxygenation: an in vitro model for assessment of the neuroprotective effects of estrogen. Cell Mol Neurobiol 19:705-718.